CRANBURY, N.J., March 13 /PRNewswire-FirstCall/ -- Innophos Holdings, Inc. (Nasdaq: IPHS), a leading specialty phosphate producer in North America, today announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2008 with the Securities and Exchange Commission on March 12, 2009.

The Company reported that the financial statements included in the 10-K contain revisions to the previously released consolidated statement of income. These revisions reflect non-cash gains related to deferred income taxes and deferred statutory profit sharing for its Mexican subsidiary. These gains favorably affected net income by approximately $6.7 million, or $0.31 per share.

The 2008 year end net income reported in an earlier press release was $200.5 million, and the net income amount reflected in the revised statement of operations is $207.2 million.

Additional information concerning the revisions can be found in notes to the Company's financial statements included in its Form 10-K.

About Innophos Holdings, Inc.

Innophos Holdings, Inc. (www.innophos.com), the holding company for a leading North American manufacturer of specialty phosphates, serves a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos' market-leading positions derive from its experience and dedication to customer service and innovation. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico). 'IPHS-G'

SOURCE Innophos Holdings, Inc.